Development of an effective Japanese encephalitis virus-specific DNA vaccine

Microbes and Infection

Volumn 8, Issue 11, 2006, Pages 2578-2586

  Wu, Chang Jer ^a   Li, Tsung Lin ^a   Huang, Hui Wen ^a   Tao, Mi Hua ^b   Chan, Yi Lin ^c  

^a NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

DNA vaccine; Intramuscular injection; Japanese encephalitis virus; Virus like particle

Indexed keywords

ANTIBODY; ANTIGEN; CARDIOTOXIN; DNA VACCINE; ENVELOPE PROTEIN; GROWTH HORMONE; JAPANESE ENCEPHALITIS VACCINE; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; CHIMERA; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; ELECTRON MICROSCOPY; EXPRESSION VECTOR; FEMALE; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; INTRON; JAPANESE ENCEPHALITIS VIRUS; MOUSE; NONHUMAN; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; VIRUS INFECTION; VIRUS PARTICLE;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CELL LINE; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; GENETIC VECTORS; INJECTIONS, INTRAMUSCULAR; INTRONS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, ANIMAL; NEUTRALIZATION TESTS; RNA 3' POLYADENYLATION SIGNALS; SURVIVAL ANALYSIS; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

ANIMALIA; BOS TAURUS; JAPANESE ENCEPHALITIS VIRUS; PRIMATES;

EID: 33750020229     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.06.010     Document Type: Article

References (30)

1. Burke D.S., and Monath T.P. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. fourth ed. (2001), Lippincott Williams & Wilkins Publishers, Philadelphia, PA 1043-1125
2. Tsai T.F., Chang G.J., and Yu Y.X. In: Stanley A.P., and Orenstein W.A. (Eds). Vaccines. third ed. (1999), W.B. Saunders, Philadelphia, PA 672-710
3. Sakaguchi M., Yoshida M., Kuroda W., Harayama O., Matsunaga Y., and Inouye S. Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines. Vaccine 15 (1997) 121-122
4. Poland J.D., Cropp C.B., Craven R.B., and Monath T.P. Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants. J. Infect. Dis. 161 (1990) 878-882
5. Juang R.F., Okuno Y., Fukunaga T., Tadano M., Fukai K., Baba K., Tsuda N., Yamada A., and Yabuuchi H. Neutralizing antibody responses to Japanese encephalitis vaccine in children. Biken J. 26 (1983) 25-34
6. Tang D.C., DeVit M., and Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature 356 (1992) 152-154
7. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeWitt C.M., Friedman A., Hawe L.A., Leander K.R., Martinez D., Perry H.C., Shiver J.W., Montgomery D.L., and Liu M.A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259 (1993) 1745-1749
8. Xiang Z.Q., Spitalnik S., Tran M., Wunner W.H., Cheng J., and Ertl H.C.J. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199 (1994) 132-140
9. Sedegah M., Hedstrom R., Hobart P., and Hoffman S.L. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 9866-9870
10. Tascon R.E., Colston M.J., Ragno S., Stavropoulos E., Gregory D., and Lowrie D.B. Vaccination against tuberculosis by DNA injection. Nat. Med. 2 (1996) 888-892
11. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., and Robinson H.L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 11478-11482
12. Chapman B.S., Thayer R.M., Vincent K.A., and Haigwood N.L. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res. 19 (1991) 3979-3986
13. Huang M.T.F., and Gorman C.M. Intervening sequences increase efficiency of RNA 3′ processing and accumulation of cytoplasmic RNA. Nucleic Acids Res. 18 (1990) 937-946
14. Proudfoot N.J. Poly(A) signals. Cell 64 (1991) 671
15. Lindenbach B.D., and Rice C.M. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. fourth ed. (2001), Lippincott Williams & Wilkins Publishers, Philadelphia, PA 991-1041
16. Konishi E., and Mason P.W. Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J. Virol. 67 (1993) 1672-1675
17. Chen H.W., Pan C.H., Liau M.Y., Jou R., Tsai C.J., Wu H.J., Lin Y.L., and Tao M.H. Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines. J. Virol. 73 (1999) 10137-10145
18. Pan C.H., Chen H.W., Huang H.W., and Tao M.H. Protective mechanisms induced by a Japanese encephalitis virus DNA vaccine: requirement for antibody but not CD8(+) cytotoxic T-cell responses. J. Virol. 75 (2001) 11457-11463
19. Wu S.C., Lian W.C., Hsu L.C., and Liau M.Y. Japanese encephalitis virus antigenic variants with characteristic differences in neutralization resistance and mouse virulence. Virus Res. 51 (1997) 173-181
20. Choi T., Huang M., Gorman C., and Jaenisch R. A generic intron increases gene expression in transgenic mice. Mol. Cell Biol. 11 (1991) 3070-3074
21. Miura K., Onodera T., Nishida A., Goto N., and Fujisaki Y. A single gene controls resistance to Japanese encephalitis virus in mice. Arch. Virol. 112 (1990) 261-270
22. Wu C.J., Lee S.C., Huang H.W., and Tao M.H. In vivo electroporation of skeletal muscle increases the efficacy of Japanese encephalitis virus DNA vaccine. Vaccine 22 (2004) 1457-1464
23. Barry M.A., and Johnston S.A. Biological features of genetic immunization. Vaccine 15 (1997) 788-791
24. Harms J., and Splitter G. Interferon-γ inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Hum. Gene Ther. 6 (1995) 1291-1297
25. Heinz F.X. Epitope mapping of flavivirus glycoproteins. Adv. Virus Res. 31 (1986) 103-168
26. Chambers T.J., Hahn C.S., Galler R., and Rice C.M. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 44 (1990) 649-688
27. Stadler K., Allison S.L., Schalich J., and Heinz F.X. Proteolytic activation of tick-borne encephalitis virus by furin. J. Virol. 71 (1997) 8475-8481
28. Wengler G., and Wengler G. Cell-associated West Nile flavivirus is covered with E + pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release. J. Virol. 63 (1989) 2521-2526
29. Condon C., Watkins S.C., Celluzzi C.M., Thompson K., and Falo Jr. L.D. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2 (1996) 1122-1128
30. Konishi E., Yamaoka M., Khin-Sane-WinKurane I., and Mason P.W. Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes. J. Virol. 72 (1998) 4925-4930